106190 — High Tech Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩109bn
- KR₩120bn
- KR₩77bn
- 36
- 52
- 43
- 36
Annual cashflow statement for High Tech Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4,218 | -3,152 | -1,225 | 4,028 | 9,864 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1,739 | 1,566 | 1,592 | 2,212 | 1,898 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -540 | -11,557 | 1,011 | -15,488 | -13,839 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,484 | -7,691 | 6,928 | -3,703 | 2,909 |
| Capital Expenditures | -2,157 | -937 | -860 | -656 | -5,091 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -4,161 | 6,952 | -432 | 1,386 | -1,664 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6,319 | 6,015 | -1,292 | 730 | -6,755 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3,022 | -393 | 4,621 | -390 | -529 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -857 | -2,071 | 10,237 | -3,394 | -4,398 |